Hyperbaric Oxygen Treatment (HBOT)

DEVICE3 trials

Sponsors

Hennepin Healthcare Research Institute, University of California, San Francisco, Jay C. Buckey Jr.

Conditions

Acute COVID-19Anastomosis, LeakingAutismAvascular Necrosis of BoneAxonotmesisBranch Retinal Artery OcclusionCalciphylaxisCartilage Injury

Phase 2

Comparison Between Different Types of Oxygen Treatment Following Traumatic Brain Injury

CompletedNCT00170352

Hennepin Healthcare Research InstituteTraumatic Brain Injury

Start: 2002-11-30End: 2008-11-30Updated: 2015-08-28

Phase 3

Pilot Study of the Effect of Hyperbaric Oxygen Treatment on Behavioral and Biomarker Measures in Children With Autism

CompletedNCT00584480

University of California, San FranciscoAutism

Start: 2007-10-31End: 2009-09-30Updated: 2012-08-07

Phase 4

Emerging Indications for Hyperbaric Oxygen Treatment

Not yet recruitingNCT07240649

Jay C. Buckey Jr.Acute COVID-19, Anastomosis, Leaking, Avascular Necrosis of Bone +38

Start: 2026-11-01End: 2035-12-01Target: 100Updated: 2026-09-09

Related Papers

A prospective, randomized Phase II clinical trial to evaluate the effect of combined hyperbaric and normobaric hyperoxia on cerebral metabolism, intracranial pressure, oxygen toxicity, and clinical outcome in severe traumatic brain injury.

2013-03-19100 citations